|Purity by SDS Page||≥98%|
|Purity by HPLC||≥98%|
|Endotoxin Level||≤1 EU/µg|
|Biological Activity||Determined by its ability to inhibit 5.0ng/ml of BMP-4 induced alkaline phosphatase production by ATDC chondrogenic cells. The expected ED50 for this effect is 1.0-2.0 ng/ml of Noggin|
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.